Angiotensin-converting enzyme inhibition limits dysfunction in adjacent noninfarcted regions during left ventricular remodeling

Journal of the American College of Cardiology

Volumn 27, Issue 1, 1996, Pages 211-217

  Kramer, Christoper M ^a,c   Ferrari, Victor A ^b   Rogers, Walter J ^a   Theobald, Therese M ^a   Nance, Michael L ^b   Axel, Leon ^b   Reichek, Nathaniel ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c ALLEGHENY GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; RAMIPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0030043810     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(95)00429-7     Document Type: Article

References (31)

1. McKay RG, Pfeffer MA, Pasternak RC, et al. Left ventricular remodeling following myocardial infarction: a corollary to infarct expansion. Circulation 1986;74:693-702.
2. Eaton LW, Weiss JL, Bulkley BH, Garrison JB, Weisfeldt MD. Regional cardiac dilatation after acute myocardial infarction. N Engl J Med 1979;300: 57-62.
3. Erlebacher JA, Weiss JL, Easton LW, Kallman C, Weisfeldt ML, Buckley BH. Late effects of acute infarct dilation on heart size: a two dimensional echocardiographic study. Am J Cardiol 1982;49:1120-6.
4. Pfeffer MA, Pfeffer JM, Fishbein MC, et al. Myocardial infarct size and ventricular function in rats. Circ Res 1979;44:503-12.
5. Hammermeister KE, DeRouen TA, Dodge HT. Variables predictive of survival in patients with coronary disease: selection by univariate and multivariate analyses from the clinical, electrocardiographic, exercise, arteriographic, and quantitative angiographic evaluations. Circulation 1979;59: 421-30.
6. White HD, Norris RM, Brown MA, Brandt PWT, Whitlock RML, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987;76:44-51.
7. Jugdutt BI, Warnica JW. Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion, and complications. Circulation 1988;78:906-19.
8. Mitchell GF, Lamas GA, Vaughan DE, Pfeffer MA. Left ventricular remodeling in the year after first anterior myocardial infarction. J Am Coll Cardiol 1992;19:1136-44.
9. Kramer CM, Lima JAC, Reichek N, et al. Regional function within noninfarcted myocardium during left ventricular remodeling. Circulation 1993;88:1279-88.
10. Zerhouni E, Parrish D, Rogers WJ, Yang A, Shapiro EP. Human heart: tagging with MR imaging - a method for noninvasive measurement of myocardial motion. Radiology 1988;169:59-64.
11. Axel L, Dougherty L, MR imaging of motion with spatial modulation of magnetization. Radiology 1989;171:841-5.
12. Clark N, Reichek N, Bergey P, et al. Normal segmental myocardial function; assessment by magnetic resonance imaging using spatial modulation of magnetization. Circulation 1991;84:67-74.
13. Kramer CM, Reichek NR, Ferrari VA, Theobald T, Dawson J, Axel L. Regional heterogeneity of function in hypertrophic cardiomyopathy. Circulation 1994;90:186-94.
14. Kramer CM, Rogers WJ, Theobald T, Simonetti O, Reichek N. Remote region dysfunction early after reperfused anterior myocardial infarction; a breath-hold magnetic resonance tissue tagging study [abstract]. Circulation 1994;90 Suppl I:I-610.
15. Pfeffer JM, Pfeffer MA, Braunwald E. Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res 1985;57:84-95.
16. Pfeffer MA, Pfeffer JM, Steinberg C, Finn P. Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circulation 1985;72:406-12.
17. Jugdutt BI, Schwartz-Michorowski BL, Khan MI. Effect of long-term captopril therapy on left ventricular remodeling and function during healing of canine myocardial infarction. J Am Coll Cardiol 1992;19:713-21.
18. Jugdutt BI, Khan MI, Jugdutt SJ, Blinston GE. Effect of enalapril on ventricular remodeling and function during healing after anterior myocardial infarction in the dog. Circulation 1995;91:802-12.
19. Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1992;327:669-77.
20. The Acute Infarction Ramipril Efficacy (AIRE) study investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993;342:821-8.
21. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. GISSI-3: Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 1994;343:1115-22.
22. St. John Sutton M, Pfeffer MA, Plappert T, et al. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. Circulation 1994;89:68-75.
23. Markovitz LJ, Savage EB, Ratcliffe MB, et al. Large animal model of left ventricular aneurysm. Ann Thorac Surg 1989;48:838-45.
24. Schieffer B, Wirger A, Meybrunn M, et al. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat. Circulation 1994;89:2273-82.
25. McDonald KM, Rector T, Carlyle PF, Francis G, Cohn JN. Angiotensin-converting enzyme inhibition and beta-adrenoceptor blockade regress established ventricular remodeling in a canine model of discrete myocardial damage. J Am Coll Cardiol 1994;24:1762-8.
26. Weinberg EO, Schoen FJ, George D, et al. Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis. Circulation 1994;90:1410-22.
27. Olivetti G, Capasso JM, Meggs LG, Sonnenblick EH, Anversa P. Cellular basis of chronic ventricular remodeling after myocardial infarction in rats. Circ Res 1991;68:856-69.
28. Baker KM, Aceto JF. Angiotensin II stimulation of protein synthesis and cell growth in chick heart cells. Am J Physiol 1990;259:H610-8.
29. Minshall RD, Yelemanchi VP, Djokovic A, et al. Importance of sympathetic innervation in the positive inotropic effects of bradykinin and ramiprilat. Circ Res 1994;74:441-7.
30. Baumgarten CR, Linz W, Kunkel G, Scholkens BA, Wiemer G. Ramiprilat increases bradykinin outflow from isolated hearts of rat. Br J Pharmacol 1993;108:293-5.
31. McDonald KM, Mock J, D'Aloia A, et al. Bradykinin antagonism inhibits the antigrowth effect of converting enzyme inhibition in the dog myocardium after discrete transmural myocardial necrosis. Circulation 1995;91:2043-8.